Carboplatin/Paclitaxel/Trastuzumab Regimen

Preferred Label : Carboplatin/Paclitaxel/Trastuzumab Regimen;

NCIt synonyms : Carboplatin-Paclitaxel-Trastuzumab; Carboplatin/Paclitaxel/Trastuzumab; Carboplatin-Paclitaxel-Trastuzumab Regimen; TPC; TCH; Paclitaxel/Carboplatin/Trastuzumab; Carboplatin/Paclitaxel Plus Trastuzumab Regimen; Paclitaxel/Carboplatin Plus Trastuzumab;

NCIt related terms : Carboplatin and Paclitaxel (CP) and Trastuzumab; Carboplatin and Paclitaxel (CP) and Trastuzumab-herw; Carboplatin and Paclitaxel (CP) and Trastuzumab-dttb; Carboplatin and Paclitaxel (CP) and Trastuzumab-qyyp; Carboplatin and Paclitaxel (CP) and Trastuzumab-pkrb; Carboplatin and Paclitaxel (CP) and Trastuzumab-zerc; Carboplatin and Paclitaxel (CP) and Trastuzumab-anns; Carboplatin and Paclitaxel (CP) and Trastuzumab-dkst;

NCIt definition : A regimen consisting of paclitaxel, carboplatin and trastuzumab that may be used as a treatment for breast, esophageal and esophagogastric junction, and gastric cancers and endometrial carcinoma.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525001;

Codes from synonyms : 59563; 129449; 129061; 128964; 128867; 129352; 129255; 129158;

Details

Origin ID

C138052;

UMLS CUI

C4522240;

False automatic mappings
- Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 [OMIM gene]
- Thyroid cancer, nonmedullary, 1 [OMIM Phenotype]
- coiled-coil domain containing 6 [ORDO Gene]
- solute carrier family 25 member 19 [ORDO Gene]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients